These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 12745503)

  • 21. Cough following initiation of smoking abstinence.
    Warner DO; Colligan RC; Hurt RD; Croghan IT; Schroeder DR
    Nicotine Tob Res; 2007 Nov; 9(11):1207-12. PubMed ID: 17978996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
    Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
    Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany].
    Bergmann L; Warncke W; Herschel M
    Pneumologie; 2004 Mar; 58(3):140-6. PubMed ID: 15007784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating smoking cessation into mental health care for post-traumatic stress disorder.
    McFall M; Saxon AJ; Thaneemit-Chen S; Smith MW; Joseph AM; Carmody TP; Beckham JC; Malte CA; Vertrees JE; Boardman KD; Lavori PW
    Clin Trials; 2007; 4(2):178-89. PubMed ID: 17456521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measure methods of tobacco abstinence according to recommendations--own and Canadian research finding].
    Broszkiewicz M; Drygas W
    Przegl Lek; 2010; 67(10):914-9. PubMed ID: 21360926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking abstinence rates and reasons for failure to quit smoking in cancer patients in Jordan.
    Hawari F; Obeidat N; Beano H; Dawahrah S; Al-Rimawi D; Ghonimat I
    Respiration; 2012; 83(3):233-8. PubMed ID: 21701156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining and Measuring Abstinence in Clinical Trials of Smoking Cessation Interventions: An Updated Review.
    Piper ME; Bullen C; Krishnan-Sarin S; Rigotti NA; Steinberg ML; Streck JM; Joseph AM
    Nicotine Tob Res; 2020 Jun; 22(7):1098-1106. PubMed ID: 31271211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of individual long-term outcomes in smoking cessation trials using frailty models.
    Li Y; Wileyto EP; Heitjan DF
    Biometrics; 2011 Dec; 67(4):1321-9. PubMed ID: 21401566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring consensus on how to measure smoking cessation. A Delphi study.
    Cheung KL; de Ruijter D; Hiligsmann M; Elfeddali I; Hoving C; Evers SMAA; de Vries H
    BMC Public Health; 2017 Nov; 17(1):890. PubMed ID: 29162043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review.
    Hughes JR; Carpenter MJ; Naud S
    Nicotine Tob Res; 2010 Jul; 12(7):756-62. PubMed ID: 20504946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of four self-report smoking cessation outcome measures.
    Velicer WF; Prochaska JO
    Addict Behav; 2004 Jan; 29(1):51-60. PubMed ID: 14667420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A second look at the effects of supportive follow-up on smoking cessation.
    Kozlowski LT; Page A
    CMAJ; 1987 Oct; 137(7):605-7. PubMed ID: 3651924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes.
    Kypriotakis G; Bernstein SL; Bold KW; Dziura JD; Hedeker D; Mermelstein RJ; Weinberger AH
    Nicotine Tob Res; 2024 Jun; 26(7):796-805. PubMed ID: 38214037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The increasing recalcitrance of smokers in clinical trials.
    Irvin JE; Brandon TH
    Nicotine Tob Res; 2000 Feb; 2(1):79-84. PubMed ID: 11072444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing outcome in smoking cessation studies.
    Velicer WF; Prochaska JO; Rossi JS; Snow MG
    Psychol Bull; 1992 Jan; 111(1):23-41. PubMed ID: 1539088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trial of supportive follow-up for cigarette smokers in a family practice.
    Wilson D; Wood G; Johnston N; Sicurella J
    Can Med Assoc J; 1982 Jan; 126(2):127-9. PubMed ID: 7037143
    [No Abstract]   [Full Text] [Related]  

  • 37. Python Package abstcal: An Open-Source Tool for Calculating Abstinence From Timeline Followback Data.
    Cui Y; Robinson JD; Rymer RE; Minnix JA; Cinciripini PM
    Nicotine Tob Res; 2022 Jan; 24(1):146-148. PubMed ID: 33912971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varenicline for 4 weeks prior to target quit date reduces prequit date smoking and increases 12-week abstinence.
    Garrison GD
    Evid Based Med; 2012 Jun; 17(3):96-7. PubMed ID: 22160151
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of cigarette smokers with an oat extract].
    Raffalt GJ; Andersen B
    Ugeskr Laeger; 1975 Sep; 137(38):2177-8. PubMed ID: 1101494
    [No Abstract]   [Full Text] [Related]  

  • 40. The HubBle trial: a word of caution.
    Giordano P
    Lancet; 2016 Dec; 388(10063):2995-2996. PubMed ID: 27998536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.